☰

Paige E. Cramer, Ph.D. - Publications

Affiliations: 
2012 Neurosciences Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Neuroscience Biology, Pathology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Cramer PE, Gentzel RC, Tanis KQ, Vardigan J, Wang Y, Connolly B, Manfre P, Lodge K, Renger JJ, Zerbinatti C, Uslaner JM. Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease. Neurobiology of Aging. 64: 92-106. PMID 29353102 DOI: 10.1016/J.Neurobiolaging.2017.12.011  0.378
2014 Bomben V, Holth J, Reed J, Cramer P, Landreth G, Noebels J. Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy. Neurobiology of Aging. 35: 2091-5. PMID 24767949 DOI: 10.1016/J.Neurobiolaging.2014.03.029  0.611
2013 Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA. Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models". Science (New York, N.Y.). 340: 924-g. PMID 23704556 DOI: 10.1126/Science.1234114  0.569
2012 Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science (New York, N.Y.). 335: 1503-6. PMID 22323736 DOI: 10.1126/Science.1217697  0.651
2012 Wilkinson BL, Cramer PE, Varvel NH, Reed-Geaghan E, Jiang Q, Szabo A, Herrup K, Lamb BT, Landreth GE. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease. Neurobiology of Aging. 33: 197.e21-32. PMID 20696495 DOI: 10.1016/J.Neurobiolaging.2010.06.014  0.601
2012 Landreth G, Cramer P, Wesson D, Cirrito J, Brunden K, Wilson D. 44 ApoE-directed therapeutics for the treatment of Alzheimer's disease Neurobiology of Aging. 33: S19. DOI: 10.1016/J.Neurobiolaging.2012.01.062  0.626
2010 Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE. Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15369-73. PMID 21084593 DOI: 10.1523/Jneurosci.2637-10.2010  0.597
2009 Cramer PE, Lee CD, Wilkinson BL, Landreth GE. P4-270: Retiniod X Receptor As A Therapeutic Target For Alzheimer's Disease Alzheimer's & Dementia. 5: e9-e9. DOI: 10.1016/J.Jalz.2009.07.051  0.581
2008 Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron. 58: 681-93. PMID 18549781 DOI: 10.1016/J.Neuron.2008.04.010  0.631
Show low-probability matches.